Literature DB >> 17170968

Sinonasal undifferentiated carcinoma: current trends in treatment.

K T Pitman, P D Costantino, L F Lassen.   

Abstract

Sinonasal undifferentiated carcinoma (SNUC) is a rare and highly aggressive neoplasm of the paranasal sinuses, which has recently been characterized as a distinct pathologic entity. The prognosis for patients with SNUC is poor. Early case reports describe patients with lesions that were clinically advanced at initial presentation and surgically unresectable. Survival was reported in months after treatment with chemotherapy and radiation. As more experience was gained with treatment of SNUC, it was found that aggressive, combined surgical therapy of lesions previously considered unresectable has shown increased survival. We report a case of a 38-year-old man with SNUC originating in the posterior ethmoid, extending into the anterior cranial fossa and orbit, who was treated with preoperative hyperfractionated radiation therapy, chemotherapy, and craniofacial resection.

Entities:  

Year:  1995        PMID: 17170968      PMCID: PMC1656535          DOI: 10.1055/s-2008-1058925

Source DB:  PubMed          Journal:  Skull Base Surg        ISSN: 1052-1453


  16 in total

1.  Olfactory neuroblastoma. A clinical analysis of 17 cases.

Authors:  S Kadish; M Goodman; C C Wang
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

2.  Meta-analysis of outcome in anterior skull base resection for squamous cell and undifferentiated carcinoma.

Authors:  D E Eibling; I P Janecka; C H Snyderman; S P Cass
Journal:  Skull Base Surg       Date:  1993

3.  Prognostic factors in craniofacial surgery.

Authors:  R Van Tuyl; G S Gussack
Journal:  Laryngoscope       Date:  1991-03       Impact factor: 3.325

4.  Craniofacial resection for tumors involving the anterior skull base.

Authors:  J P Shah; D H Kraus; E Arbit; J H Galicich; E W Strong
Journal:  Otolaryngol Head Neck Surg       Date:  1992-04       Impact factor: 3.497

5.  Sinonasal undifferentiated carcinoma: a distinctive and highly aggressive neoplasm.

Authors:  P A Levine; H F Frierson; F M Stewart; S E Mills; R E Fechner; R W Cantrell
Journal:  Laryngoscope       Date:  1987-08       Impact factor: 3.325

6.  Craniofacial resections for tumors involving the base of the skull.

Authors:  J P Shah; N Sundaresan; J Galicich; E W Strong
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

7.  Craniofacial resection at the University of Virginia (1976-1992): survival analysis.

Authors:  P A Levine; R F Debo; S D Meredith; J A Jane; W C Constable; R W Cantrell
Journal:  Head Neck       Date:  1994 Nov-Dec       Impact factor: 3.147

8.  Craniofacial resection. An analysis of 73 cases.

Authors:  P J Catalano; C S Hecht; H F Biller; W Lawson; K D Post; V Sachdev; C Sen; M L Urken
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-11

9.  Sinonasal undifferentiated carcinoma: a ray of hope.

Authors:  B D Deutsch; P A Levine; F M Stewart; H F Frierson; R W Cantrell
Journal:  Otolaryngol Head Neck Surg       Date:  1993-06       Impact factor: 3.497

10.  Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma.

Authors:  H F Frierson; S E Mills; R E Fechner; J B Taxy; P A Levine
Journal:  Am J Surg Pathol       Date:  1986-11       Impact factor: 6.394

View more
  3 in total

1.  [Sinonasal undifferentiated carcinoma. A rare and aggressive neoplasm of the nasal cavity and paranasal sinuses].

Authors:  O Reichel; S Ihrler; F Born; M Andratschke; G Rasp; H Hagedorn
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

2.  Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States.

Authors:  Kyle J Chambers; Ashton E Lehmann; Aaron Remenschneider; Matthew Dedmon; Josh Meier; Stacey T Gray; Derrick T Lin
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-29

3.  A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases.

Authors:  Julianna Sienna; Nhu-Tram Nguyen; Julie Arsenault; Ian Hodson; Brandon Meyers
Journal:  Cureus       Date:  2018-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.